Pennsylvania Workers' Comp Pharmacy Benefits: What PI Attorneys Must Know

James Wong — Founder & Pharmacist, LienScripts | February 19, 2026 | 8 min read

Pennsylvania workers' compensation pharmacy benefits are tightly controlled under 77 P.S. § 501 et seq., the Bureau of Workers' Compensation drug formulary, and Act 111 of 2018 opioid restrictions — leaving critical gaps that a pharmacy lien can fill when a third-party PI claim runs alongside a construction or manufacturing injury case.

Pennsylvania Workers' Comp Pharmacy Benefits: What PI Attorneys Must Know

Pennsylvania workers' compensation cases that involve a negligent third party are among the highest-value dual-track opportunities in personal injury law. Construction accidents, manufacturing injuries, and workplace incidents caused by subcontractors or third-party equipment manufacturers routinely produce simultaneous workers' comp claims and third-party PI actions. Each claim runs on its own pharmaceutical track — and the gap between what Pennsylvania workers' comp will pay and what a pharmacy lien can cover is substantial, particularly after the Act 111 of 2018 opioid formulary restrictions took effect.

Pennsylvania Workers' Compensation Pharmacy: The Statutory Framework

Pennsylvania workers' compensation pharmacy benefits are governed by the Pennsylvania Workers' Compensation Act, 77 P.S. § 501 et seq. The Bureau of Workers' Compensation (BWC), operating within the Pennsylvania Department of Labor and Industry, administers the program and has promulgated a drug formulary — along with utilization review regulations at 34 Pa. Code § 127 — that directly controls which medications carriers must authorize and which require additional scrutiny.

The Pennsylvania workers' comp formulary designates medications in a tiered structure:

• Formulary drugs: Medications on the approved list that carriers must cover for compensable conditions without additional prior authorization, subject to the authorized treating physician's prescription
• Non-formulary drugs: Medications not on the approved list that require explicit prior authorization from the carrier before the pharmacy will dispense

Non-formulary designations create preauthorization delays that frequently leave injured workers without medication. Pennsylvania carriers typically have defined response windows for prior authorization requests, and denials are routine for compound medications, specialty biologics, brand-name drugs with generic formulary equivalents, and medications the carrier contends are not causally related to the work injury.

[!SOURCE] Pennsylvania workers' compensation medical benefits, including pharmacy, are governed by 77 P.S. § 501 et seq. Utilization review procedures are codified at 34 Pa. Code § 127. The Bureau of Workers' Compensation publishes its formulary and medical cost containment rules at https://www.dli.pa.gov/Businesses/Compensation/WC/Pages/default.aspx

The Employer's 90-Day Right to Direct Care: LIBC-503

One of the most significant features of the Pennsylvania workers' comp system is the employer's right to direct medical care during the first 90 days of a claim under the LIBC-503 designated provider list requirement. Under the Pennsylvania Workers' Compensation Act, an employer that posts a list of at least six designated health care providers — including at least three physicians — may require the injured worker to treat exclusively with those providers for the first 90 days of the claim.

During this 90-day directed-care period, prescriptions from providers outside the employer's designated list are not covered under workers' comp. For PI attorneys, this means the treating physician on the PI track — who is almost always outside the employer's LIBC-503 panel — cannot route prescriptions through the workers' comp system during this critical early treatment period. A pharmacy lien program operating independently of the comp system fills this gap immediately, allowing PI-track prescriptions to be covered from day one of treatment.

Act 111 of 2018: Opioid Formulary Restrictions

Pennsylvania's Act 111 of 2018 substantially tightened the workers' comp formulary with respect to opioid medications. The Act imposed a closed formulary for opioids — meaning that opioid prescriptions must appear on the approved drug list and comply with dose and duration limits, or they require specific prior authorization from the carrier. Prescriptions for opioids that exceed the formulary thresholds — in dose, duration, or morphine milligram equivalent — are subject to denial or automatic referral to utilization review.

For PI attorneys handling cases involving construction falls, crushing injuries, post-surgical pain management, or other high-acuity conditions, Act 111 creates a predictable pharmacy gap. A treating physician on the PI track may prescribe opioid medications at doses or durations appropriate to the clinical presentation — but the workers' comp carrier, operating under Act 111's closed formulary, may refuse to cover those prescriptions entirely. The pharmacy lien covers PI-track prescriptions without being subject to the workers' comp formulary, providing the injured worker with access to clinically indicated medication while the workers' comp dispute proceeds.

[!KEY] Pennsylvania's Act 111 of 2018 opioid formulary restrictions are among the strictest in any state workers' comp system. For construction and manufacturing injury cases — where high-acuity pain management needs are common — Act 111 denials create predictable pharmacy gaps that a pharmacy lien can fill on the concurrent PI track without the formulary constraints that bind the workers' comp carrier.

Compound Medication Denials in Pennsylvania Workers' Comp

Compound medications are among the most consistently denied categories in Pennsylvania workers' comp. The BWC formulary does not include compounded preparations as a class, and carriers routinely deny compound creams, gels, and topical analgesics on the grounds that single-ingredient formulary equivalents exist. Utilization review under 34 Pa. Code § 127 is frequently used to challenge the medical necessity of compounds that the treating physician has prescribed.

For PI patients — particularly those managing soft tissue injuries, neuropathic pain, or post-surgical discomfort — topical compound medications are often the most effective tool for targeted pain control with minimal systemic side effects. A pharmacy lien program allows the treating physician on the PI case to prescribe these formulations and have them filled through the lien-enrolled pharmacy, independent of the workers' comp formulary restrictions.

Utilization Review Under 34 Pa. Code § 127

Pennsylvania's utilization review (UR) process is one of the most procedurally detailed in the country. Under 34 Pa. Code § 127, a carrier may request utilization review of any treatment — including medications — that it contends is not reasonable or necessary. The UR process involves:

1. The carrier submitting a request to a BWC-certified utilization review organization (URO)
2. The URO conducting a peer review of the medical records and treatment at issue
3. The URO issuing a determination on the reasonableness and necessity of the treatment
4. If adverse, the treating physician or injured worker may request a reconsideration and ultimately a hearing before a Workers' Compensation Judge

This process can take months. During the pendency of a UR dispute, the carrier may withhold payment for the disputed medication. A pharmacy lien short-circuits the waiting game: the PI-track treating physician prescribes, the lien pharmacy fills, and the client has medication access while the workers' comp UR dispute runs its course.

[!SOURCE] Pennsylvania utilization review of workers' comp medical treatment — including pharmacy — is governed by 34 Pa. Code § 127. Workers' Compensation Judges have jurisdiction over UR appeals under 77 P.S. § 531.

Third-Party PI Claim Intersection: 77 P.S. § 671

Pennsylvania law preserves the injured worker's right to pursue a third-party civil action while simultaneously receiving workers' comp benefits under 77 P.S. § 671. The statute grants the workers' comp employer/insurer a right of subrogation against the third-party PI recovery for all benefits paid — including medical benefits and pharmacy costs.

The Pennsylvania subrogation statute is broadly written and is vigorously enforced by carriers. However, the subrogation lien only attaches to what the carrier actually paid. Medications filled through the pharmacy lien are PI-track expenses — they were never billed to or paid by the workers' comp carrier. This means that the pharmacy lien balance sits entirely outside the carrier's subrogation calculation under § 671, and the full value of the lien inures to the demand package for the PI case.

This distinction is particularly valuable in high-volume dual-claim contexts — construction accidents, manufacturing line injuries, and logistics worker collisions — where the workers' comp carrier may seek a large subrogation reimbursement from the PI settlement. Cleanly separating the PI medication record through the lien program maximizes the portion of the settlement that belongs to the client.

[!KEY] Pennsylvania's 77 P.S. § 671 subrogation right allows the workers' comp carrier to seek reimbursement from the PI settlement for all benefits it paid. Because pharmacy lien fills are PI-track expenses that were never billed to the carrier, they fall entirely outside the subrogation calculation. Enrolling in the lien program at intake — before workers' comp pharmacy benefits are exhausted or denied — is the most effective way to protect the client's net recovery.

Dual-Claim Intake Checklist for Construction and Manufacturing Injury Attorneys

When a new Pennsylvania client presents with both a workers' comp claim and a concurrent third-party PI case — as is common in construction fall, scaffolding accident, and manufacturing line injury cases — the intake checklist should address:

1. Confirm LIBC-503 status — Has the employer posted a designated provider list? Is the employer's 90-day directed-care period still active? This determines whether PI-track prescriptions can ever be routed through the comp system.
2. Identify the authorized treating physician — Which provider is designated for the comp claim, and who is treating the client on the PI track?
3. Identify the carrier's PBM and formulary — Which pharmacy benefit manager is the carrier using, and which pharmacies are in the PBM's network for workers' comp fills?
4. Enroll in the pharmacy lien program immediately — Do not wait for workers' comp denials before enrolling. Early enrollment ensures a complete PI medication record from the first day of PI-track treatment.
5. Coordinate with the PI-track treating physician — Ensure that physician routes all prescriptions to the lien-enrolled pharmacy, independent of the workers' comp PBM.
6. Collect all Act 111 and prior authorization denial documentation — Every denial letter or PA refusal from the carrier is evidence that the comp system refused medically necessary care, strengthening the argument that the PI defendant should bear those costs.
7. Monitor utilization review proceedings — If the carrier initiates UR on any medication, ensure the PI-track treating physician's records independently support clinical necessity.
8. Track post-MMI status — Calendar the workers' comp MMI determination date. When the carrier declares MMI and terminates pharmacy benefits, the continuing prescription need documented through the lien program is compensable against the tortfeasor.
9. Calculate subrogation exposure at intake — Identify the workers' comp carrier's likely subrogation claim under 77 P.S. § 671 at the outset so the settlement demand can be built with full awareness of the net recovery picture.

Building the Demand Package

In a Pennsylvania third-party PI case with concurrent workers' comp, the demand package should separately itemize:

• Medical specials paid by the workers' comp carrier (subject to the carrier's subrogation lien under 77 P.S. § 671)
• Medical specials from the pharmacy lien (PI-track expenses entirely outside the subrogation calculation)
• Future medication costs supported by the treating physician's clinical opinions on ongoing need

The pharmacy lien record provides an organized, itemized accounting of every prescription filled under the PI track — the prescription date, the medication, the clinical basis, and the lien value. For construction and manufacturing injury cases — where post-surgical medication needs can extend for years — this documentation is indispensable to supporting both past medical specials and future care damages.

Pharmacy lien balances are negotiable at settlement. Beginning that conversation early and treating the lien program as a partner in resolution consistently leads to better net recovery outcomes for clients.

Related Resources

• Construction Accident Injuries: Third-Party Claims and Pharmacy Lien Coverage
• Pharmacy Lien with No Out-of-Pocket Cost for Patients
• Medical Liens vs. Pharmacy Liens: Key Differences